Telix Pharmaceuticals TLX
NASDAQ TLX
$11.34 -0.28 (-2.41%)
At close: Sep 29, 2026 · 4:00 PM EDT

Telix Pharmaceuticals (TLX) Current Assets (2023 - 2026)

Updated

Telix Pharmaceuticals' Current Assets came in at $488.02 million for the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Current Assets (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Telix Pharmaceuticals' Current Assets was $330.28 million, down 42.1% from the prior year.

  • Going back by year, Current Assets was $570.12 million in the year ended Dec 31, 2024 (+259.3%) and $158.69 million in the year ended Dec 31, 2023.
  • The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Current Assets since the quarter ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Telix Pharmaceuticals 3.94 Bn 2.88 Bn - 488.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 488.02 Mn
Dec 31, 2025 330.28 Mn
Dec 31, 2024 600.70 Mn
Dec 31, 2023 151.36 Mn
API Access

Telix Pharmaceuticals Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=TLX&period=max&api_key=YOUR_API_KEY